Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alnylam Pharma (ALNY – Research Report), Intercept Pharma (ICPT – Research Report) and Moderna (MRNA – Research Report).
Alnylam Pharma (ALNY)
Chardan Capital analyst Keay Nakae reiterated a Buy rating on Alnylam Pharma today and set a price target of $250.00. The company’s shares closed last Wednesday at $205.21, close to its 52-week high of $212.00.
According to TipRanks.com, Nakae is a 4-star analyst with an average return of
Currently, the analyst consensus on Alnylam Pharma is a Moderate Buy with an average price target of $206.44, a -1.7% downside from current levels. In a report issued on July 28, RBC Capital also maintained a Buy rating on the stock with a $225.00 price target.
Intercept Pharma (ICPT)
B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Intercept Pharma today and set a price target of $30.00. The company’s shares closed last Wednesday at $13.98.
According to TipRanks.com, Mamtani is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Intercept Pharma with a $28.38 average price target, representing a 124.9% upside. In a report released today, Piper Sandler also maintained a Buy rating on the stock with a $82.00 price target.
Needham analyst Joseph Stringer maintained a Hold rating on Moderna today. The company’s shares closed last Wednesday at $188.68.
According to TipRanks.com, Stringer has 0 stars on 0-5 stars ranking scale with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Moderna with a $216.55 average price target, a 29.1% upside from current levels. In a report issued on August 1, J.P. Morgan also initiated coverage with a Hold rating on the stock with a $165.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ALNY:
- Conduent (CNDT) Gets a Hold Rating from Needham
- O-I Glass (OI) Receives a Sell from KeyBanc
- Analysts Offer Insights on Financial Companies: Hanover Insurance (THG) and Whitestone REIT (WSR)
- LivaNova (LIVN) Gets a Buy Rating from Needham
- Barrington Believes Heritage-Crystal Clean (HCCI) Won’t Stop Here